Eli Lilly (LLY) EV to EBITDA (2009 - 2026)
Eli Lilly's EV to EBITDA was 24.06 in Q3 2026, down 6.9% from 25.83 a year earlier and down 13.5% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EV to EBITDA (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's EV to EBITDA was 23.59 through Sep 30, 2026, down 7.4% year-over-year; for FY2025, it came in at 32.25, down 20.6% from FY2024.
- In earlier years, EV to EBITDA was 40.60 in FY2024 (-13.2%), 46.76 in FY2023 (+29.3%), 36.15 in FY2022 (+23.7%) and 29.22 in FY2021 (+50.4%).
- The Q3 2026 figure marks the lowest quarterly EV to EBITDA since Q1 2021.
- Compared with a year earlier, EV to EBITDA has declined for eight straight quarters, with an average decline of 27.5% over the last eight quarters.
- The best year-over-year quarter for EV to EBITDA over five years was Q2 2023 (growth of 63.0%); the worst was Q3 2025 (a decline of 52.1%).
- Per Business Quant data, LLY's EV to EBITDA in the three quarters before Q3 2026 was 27.81 (Q2 2026), 24.26 (Q1 2026) and 32.25 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.06 |
| Jun 30, 2026 | 27.81 |
| Mar 31, 2026 | 24.26 |
| Dec 31, 2025 | 32.25 |
| Sep 30, 2025 | 25.83 |
| Jun 30, 2025 | 30.76 |
| Mar 31, 2025 | 37.74 |
| Dec 31, 2024 | 40.60 |
| Sep 30, 2024 | 53.97 |
| Jun 30, 2024 | 58.97 |
| Mar 31, 2024 | 57.38 |
| Dec 31, 2023 | 46.76 |
| Sep 30, 2023 | 46.82 |
| Jun 30, 2023 | 48.60 |
| Mar 31, 2023 | 37.87 |
| Dec 31, 2022 | 36.15 |
| Sep 30, 2022 | 30.74 |
| Jun 30, 2022 | 29.81 |
| Mar 31, 2022 | 26.80 |
| Dec 31, 2021 | 29.22 |
API Access
Eli Lilly EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();